Cost-effectiveness of apixaban compared to other new oral anticoagulants in patients with non-valvular atrial fibrillation

Authors
Category Primary study
Year 2014
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Epistemonikos ID: 4fb4d0431467ffe2d44abe8074415969bb0cf8db
First added on: Apr 19, 2023